Our in silico analysis showed that PTEN was one of the significantly inhibited upstream regulators, and loss of PTEN function is already known to enhance insulin sensitivity and promote hepatic steatosis, steatohepatitis, fibrosis, and liver cancer46,47. This evidence concerns the gene INS and Hepatic steatosis.